Lexaria Other Non Cash Items from 2010 to 2025

LEXXW Stock  USD 0.25  0  0.44%   
Lexaria Bioscience Other Non Cash Items yearly trend continues to be fairly stable with very little volatility. Other Non Cash Items will likely drop to about 190.9 K in 2025. During the period from 2010 to 2025, Lexaria Bioscience Other Non Cash Items regression line of quarterly data had mean square error of 223.1 B and geometric mean of  259,775. View All Fundamentals
 
Other Non Cash Items  
First Reported
2005-11-30
Previous Quarter
37.8 K
Current Value
16.1 K
Quarterly Volatility
263.7 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 129 K, Interest Expense of 125.2 K or Other Operating Expenses of 7.5 M, as well as many indicators such as Price To Sales Ratio of 140, Dividend Yield of 0.0 or PTB Ratio of 57.61. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.
  
Check out the analysis of Lexaria Bioscience Correlation against competitors.

Latest Lexaria Bioscience's Other Non Cash Items Growth Pattern

Below is the plot of the Other Non Cash Items of Lexaria Bioscience Corp over the last few years. It is Lexaria Bioscience's Other Non Cash Items historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.
Other Non Cash Items10 Years Trend
Pretty Stable
   Other Non Cash Items   
       Timeline  

Lexaria Other Non Cash Items Regression Statistics

Arithmetic Mean380,397
Geometric Mean259,775
Coefficient Of Variation120.78
Mean Deviation276,171
Median223,002
Standard Deviation459,441
Sample Variance211.1B
Range1.9M
R-Value0.12
Mean Square Error223.1B
R-Squared0.01
Significance0.67
Slope11,207
Total Sum of Squares3.2T

Lexaria Other Non Cash Items History

2025190.9 K
2024200.9 K
2023174.7 K
2022530.3 K
2021M
202092.9 K
2019100 K

About Lexaria Bioscience Financial Statements

Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Other Non Cash Items, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Non Cash Items200.9 K190.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.